2 months ago
ALXO
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 21%
#1025 out of 4868 analysts
Average Return
+5.8%
Win Rate
40%24 out of 60
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +221.62% | $9.02 | $29.01 | 2023-10-25 - 2024-10-24 | Strong Buy |
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-24 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +117.10% | $67.67 | $146.91 | 2020-01-03 - 2020-12-31 | Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
6 months ago
DNLI
a year ago
NUVB
a year ago
ALXO
2 years ago
ALGS
2 years ago
MRNA
2 years ago
BIIB
3 years ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $135.00 | +50.84% | Initiates Coverage On | a month ago |
Alx Oncology Holdings IncALXO | 4 | Strong Buy | $3.00 | +455.56% | Upgrades | 2 months ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $3.00 | -34.35% | Downgrades | 3 months ago |
Kodiak Sciences IncKOD | 3 | Strong Buy | $20.00 | +358.72% | Upgrades | 5 months ago |
Biogen IncBIIB | 5 | Hold | $180.00 | +48.66% | Downgrades | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $550.00 | +7.95% | Upgrades | 5 months ago |
Amgen IncAMGN | 5 | Strong Buy | $380.00 | +30.62% | Maintains | 6 months ago |
Denali Therapeutics IncDNLI | 2 | Strong Buy | $45.00 | +170.27% | Maintains | 6 months ago |
Moderna IncMRNA | 8 | Hold | $55.00 | +92.71% | Maintains | 7 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $35.00 | +233.65% | Initiates Coverage On | 7 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $40.00 | +283.14% | Initiates Coverage On | 8 months ago |
Axon Enterprise IncAXON | 3 | Strong Buy | $385.00 | -37.22% | Initiates Coverage On | 9 months ago |
Nuvation Bio IncNUVB | 3 | Strong Buy | $10.00 | N/A | Upgrades | a year ago |
Immuneering CorpIMRX | 2 | Hold | $3.00 | N/A | Downgrades | a year ago |
LianbioLIANY | 2 | Hold | $4.00 | N/A | Downgrades | a year ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | N/A | Downgrades | a year ago |
Beam Therapeutics IncBEAM | 2 | Hold | $30.00 | N/A | Downgrades | a year ago |
Amarin Corp PLCAMRN | 8 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Scholar Rock Holding CorpSRRK | 2 | Strong Buy | $20.00 | N/A | Upgrades | 2 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | N/A | Downgrades | 2 years ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $75.00 | N/A | Upgrades | 2 years ago |
Ventyx Biosciences IncVTYX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 4 years ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 4 years ago |
Fibrogen IncFGEN | 2 | Hold | $45.00 | N/A | Downgrades | 4 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 4 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $120.00 | N/A | Downgrades | 4 years ago |
Schrodinger IncSDGR | 1 | Strong Buy | $75.00 | N/A | Upgrades | 5 years ago |
Inhibrx IncINBX1 | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 6 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 6 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 7 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $3,000.00 | N/A | Maintains | 8 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 8 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.